Biotech CEOs face unique sectoral challenges such as limited capital, insufficient infrastructure, competition over talent and specific gaps in managerial knowledge and skills.

The BioLead program is a series of moderated monthly meetings of an intimate group, of Biotech C-level leaders enabling participants with an open and discrete peer learning in a facilitated and safe environment, as well as moderated sessions by global KOLs discussing specific challenges mutually defined by the group.

 

Additional sector specific groups for C-level executives in the medical device and digital health fields are planned to kickoff soon. Stay tuned.